Annual D&A
$43.71 M
+$89.00 K+0.20%
December 31, 2024
Summary
- As of February 18, 2025, TXG annual depreciation & amortization is $43.71 million, with the most recent change of +$89.00 thousand (+0.20%) on December 31, 2024.
- During the last 3 years, TXG annual D&A has risen by +$15.45 million (+54.70%).
- TXG annual D&A is now at all-time high.
Performance
TXG Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$10.56 M
-$186.00 K-1.73%
December 1, 2024
Summary
- As of February 18, 2025, TXG quarterly depreciation & amortization is $10.56 million, with the most recent change of -$186.00 thousand (-1.73%) on December 1, 2024.
- Over the past year, TXG quarterly D&A has dropped by -$186.00 thousand (-1.73%).
- TXG quarterly D&A is now -11.05% below its all-time high of $11.88 million, reached on June 30, 2023.
Performance
TXG Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$43.71 M
-$1.14 M-2.55%
December 1, 2024
Summary
- As of February 18, 2025, TXG TTM depreciation & amortization is $43.71 million, with the most recent change of -$1.14 million (-2.55%) on December 1, 2024.
- Over the past year, TXG TTM D&A has dropped by -$1.14 million (-2.55%).
- TXG TTM D&A is now -6.00% below its all-time high of $46.50 million, reached on March 31, 2024.
Performance
TXG TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TXG Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.2% | -1.7% | -2.5% |
| 3 y3 years | +54.7% | -1.7% | -2.5% |
| 5 y5 years | +518.6% | -1.7% | -2.5% |
TXG Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +54.7% | -11.1% | +44.2% | -6.0% | +54.7% |
| 5 y | 5-year | at high | +518.6% | -11.1% | +271.3% | -6.0% | +518.6% |
| alltime | all time | at high | +1019.3% | -11.1% | +919.7% | -6.0% | +4118.9% |
10x Genomics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $43.71 M(+0.2%) | - | - |
| Dec 2024 | - | $10.56 M(-1.7%) | $43.71 M(-2.5%) |
| Sep 2024 | - | $10.75 M(-1.4%) | $44.85 M(-1.5%) |
| Jun 2024 | - | $10.90 M(-5.2%) | $45.52 M(-2.1%) |
| Mar 2024 | - | $11.49 M(-1.8%) | $46.50 M(+6.6%) |
| Dec 2023 | $43.62 M(+32.2%) | $11.71 M(+2.5%) | $43.62 M(+8.0%) |
| Sep 2023 | - | $11.42 M(-3.8%) | $40.38 M(+8.9%) |
| Jun 2023 | - | $11.88 M(+37.8%) | $37.08 M(+10.2%) |
| Mar 2023 | - | $8.62 M(+1.7%) | $33.65 M(+1.9%) |
| Dec 2022 | $33.01 M(+16.8%) | $8.47 M(+4.4%) | $33.01 M(+3.6%) |
| Sep 2022 | - | $8.12 M(-3.9%) | $31.86 M(+2.7%) |
| Jun 2022 | - | $8.44 M(+5.9%) | $31.02 M(+4.2%) |
| Mar 2022 | - | $7.97 M(+8.9%) | $29.76 M(+5.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $28.25 M(+48.5%) | $7.32 M(+0.7%) | $28.25 M(+7.2%) |
| Sep 2021 | - | $7.28 M(+1.2%) | $26.35 M(+10.0%) |
| Jun 2021 | - | $7.19 M(+11.1%) | $23.95 M(+12.8%) |
| Mar 2021 | - | $6.47 M(+19.4%) | $21.23 M(+11.6%) |
| Dec 2020 | $19.02 M(+169.2%) | $5.42 M(+11.1%) | $19.02 M(+15.6%) |
| Sep 2020 | - | $4.88 M(+9.2%) | $16.45 M(+20.8%) |
| Jun 2020 | - | $4.47 M(+4.9%) | $13.61 M(+32.3%) |
| Mar 2020 | - | $4.26 M(+49.7%) | $10.29 M(+45.6%) |
| Dec 2019 | $7.07 M(+80.9%) | $2.85 M(+39.4%) | $7.07 M(+67.4%) |
| Sep 2019 | - | $2.04 M(+78.4%) | $4.22 M(+93.6%) |
| Jun 2019 | - | $1.14 M(+10.4%) | $2.18 M(+110.4%) |
| Mar 2019 | - | $1.04 M | $1.04 M |
| Dec 2018 | $3.90 M(-9.3%) | - | - |
| Dec 2017 | $4.30 M | - | - |
FAQ
- What is 10x Genomics annual depreciation & amortization?
- What is the all time high annual D&A for 10x Genomics?
- What is 10x Genomics annual D&A year-on-year change?
- What is 10x Genomics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for 10x Genomics?
- What is 10x Genomics quarterly D&A year-on-year change?
- What is 10x Genomics TTM depreciation & amortization?
- What is the all time high TTM D&A for 10x Genomics?
- What is 10x Genomics TTM D&A year-on-year change?
What is 10x Genomics annual depreciation & amortization?
The current annual D&A of TXG is $43.71 M
What is the all time high annual D&A for 10x Genomics?
10x Genomics all-time high annual depreciation & amortization is $43.71 M
What is 10x Genomics annual D&A year-on-year change?
Over the past year, TXG annual depreciation & amortization has changed by +$89.00 K (+0.20%)
What is 10x Genomics quarterly depreciation & amortization?
The current quarterly D&A of TXG is $10.56 M
What is the all time high quarterly D&A for 10x Genomics?
10x Genomics all-time high quarterly depreciation & amortization is $11.88 M
What is 10x Genomics quarterly D&A year-on-year change?
Over the past year, TXG quarterly depreciation & amortization has changed by -$186.00 K (-1.73%)
What is 10x Genomics TTM depreciation & amortization?
The current TTM D&A of TXG is $43.71 M
What is the all time high TTM D&A for 10x Genomics?
10x Genomics all-time high TTM depreciation & amortization is $46.50 M
What is 10x Genomics TTM D&A year-on-year change?
Over the past year, TXG TTM depreciation & amortization has changed by -$1.14 M (-2.55%)